Trials / Completed
CompletedNCT03962478
Combined Stent Insertion and HIFU Ablation for Pancreatic Carcinoma With Biliary Obstruction
Combined Stent Insertion and High-intensity Focused Ultrasound Ablation for Pancreatic Carcinoma With Biliary Obstruction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Xuzhou Central Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the clinical effectiveness and long-term outcomes between patients with pancreatic carcinoma and biliary obstruction who are treated by stent insertion with or without high-intensity focused ultrasound ablation.
Detailed description
Distal malignant biliary obstruction is a common problem in patients with pancreatic carcinoma. In unresectable pancreatic carcinomas, percutaneous stent placement has been pivotal in providing relief from obstructive jaundice, improving the quality of life, and allowing the maintenance of anticancer treatment. Venous chemotherapy, transcatheter arterial chemoembolization, or radiotherapy have been used to prolong stent patency and survival after stent insertion for patients with pancreatic carcinoma and biliary obstruction. High-intensity focused ultrasound ablation is a noninvasive and atoxic treatment of malignant tumor using focused ultrasound energy from an extracorporeal source that is targeted within the body resulting in thermally induced necrosis and apoptosis. The purpose of this study is to compare the clinical effectiveness and long-term outcomes between patients with pancreatic carcinoma and biliary obstruction who are treated by stent insertion with or without high-intensity focused ultrasound ablation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | biliary stent and high-intensity focused ultrasound ablation system | Self-expandable biliary nitinol alloys stent and YDME FEP-BY02 high-intensity focused ultrasound equipment |
| DEVICE | biliary stent | Self-expandable biliary nitinol alloys stent |
Timeline
- Start date
- 2019-05-31
- Primary completion
- 2020-02-08
- Completion
- 2020-09-28
- First posted
- 2019-05-24
- Last updated
- 2020-09-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03962478. Inclusion in this directory is not an endorsement.